Author: Ratha, Sachitra K.; Renuka, Nirmal; Rawat, Ismail; Bux, Faizal
Title: Prospectives of algae derived nutraceuticals as supplements for combating COVID-19 and human coronavirus diseases Cord-id: is336owo Document date: 2020_11_21
ID: is336owo
Snippet: The outbreak of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) that has created huge trepidation worldwide, has a mortality rate of 0.5-1% which is growing incessantly. There are currently no therapies and/or vaccines that may help to abate this viral disease but the use of masks and social distancing can limit the spread. Boosting immunity has been a simple way to resist viral infection and limit fatalities. In this context, the use of nutraceuticals appears to b
Document: The outbreak of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) that has created huge trepidation worldwide, has a mortality rate of 0.5-1% which is growing incessantly. There are currently no therapies and/or vaccines that may help to abate this viral disease but the use of masks and social distancing can limit the spread. Boosting immunity has been a simple way to resist viral infection and limit fatalities. In this context, the use of nutraceuticals appears to be a potential panacea. The ability of algae-based nutraceuticals, mainly Spirulina for boosting immunity against viral diseases has already been reported clinically. Spirulina-based nutraceuticals boost the adaptive and innate immunity, and bioactive compounds such as ACE inhibitor peptides, phycobiliproteins, sulfated polysaccharides, and calcium-spirulan can serve as antiviral agents. The presence of these molecules indicates its potential role in resisting infection and the COVID-19 disease progression. This review focuses on the potential role of algal nutraceuticals as immune boosters for combating human coronavirus and other viral diseases. The potential use of Spirulina-based nutraceuticals for combating COVID-19, its mechanism, and future directions have also been discussed.
Search related documents:
Co phrase search for related documents- ace activity and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8
- ace activity and acute lung injury: 1, 2, 3, 4, 5, 6, 7, 8
- ace activity and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- ace activity decrease and acute sars cov respiratory syndrome coronavirus: 1
- ace activity inhibit and acute sars cov respiratory syndrome coronavirus: 1
- ace catalytic activity and acute lung injury: 1
- ace enzyme inhibitor and action mechanism: 1, 2
- ace enzyme inhibitor and acute ards respiratory distress syndrome: 1, 2, 3, 4
- ace enzyme inhibitor and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5
- ace inhibit activity and acute sars cov respiratory syndrome coronavirus: 1
- ace inhibition and acute ards respiratory distress syndrome: 1
- ace inhibition and acute lung injury: 1, 2, 3
- ace inhibition and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5
- ace inhibition and acute tissue injury: 1
- ace inhibitor and action mechanism: 1, 2, 3, 4
- ace inhibitor and acute ards respiratory distress syndrome: 1, 2, 3, 4
- ace inhibitor and acute lung injury: 1, 2, 3, 4
- ace inhibitor and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- action mechanism and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
Co phrase search for related documents, hyperlinks ordered by date